425
Views
57
CrossRef citations to date
0
Altmetric
Research Article

Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies

, , &
Pages 313-323 | Received 24 Jul 2015, Accepted 11 Dec 2015, Published online: 12 Jan 2016

References

  • Bahra A, Gawel MJ, Hardebo J-E, et al. (2000). Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 54:1832–9
  • Barupal AK, Gupta V, Ramteke S. (2010). Preparation and characterization of ethosomes for topical delivery of aceclofenac. Indian J Pharm Sci 72:528–86
  • Basak SC, Jayakumar Reddy BM, Lucas Mani KP. (2006). Formulation and release behaviour of sustained release ambroxol hydrochloride HPMC matrix tablet. Indian J Pharm Sci 68:594–8
  • Belgamwar VS, Chauk DS, Mahajan HS, et al. (2009). Formulation and evaluation of in situ gelling system of dimenhydrinate for nasal administration. Pharm Dev Technol 14:240–8
  • Benson HA. (2005). Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2:23–33
  • Bhalerao AV, Lonkar SL, Deshkar SS, et al. (2009). Nasal mucoadhesive in situ gel of ondansetron hydrochloride. Indian J Pharm Sci 71:711–13
  • Chandler D. (2005). Interfaces and the driving force of hydrophobic assembly. Nature 437:640–7
  • Charlton S, Jones NS, Davis SS, Illum L. (2007). Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device. Eur J Pharm Sci 30:295–302
  • Dirk D, Hanssens Y. (2000). Current and emerging second-generation triptans in acute migraine therapy: a comparative review. J Clin Pharmacol 40:687–700
  • Dowson AJ, Mac Gregor EA, Purdy RA, et al. (2002). Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine. Cephalalgia 22:101–6
  • Elsayed Mustafa MA, Ossama YA, et al. (2006). Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm 322:60–6
  • Fang YP, Tsai YH, Wu PC, Huang YB. (2008). Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int J Pharm 356:144–52
  • Fang JY, Hwang TL, Leu HY. (2003). Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Int J Pharm 250:313–25
  • Goadsby PJ, Lipton RB, Ferrari MD. (2002). Migraine-current understanding and treatment. N Engl J Med 346:257–70
  • Jain SK, Chourasia MK, Jain AK, et al. (2004). Development and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery. Drug Deliv 11:113–22
  • Jones DS, Brown AF, Woolfson AD. (2003). Solute and solvent effects on the thermorheological properties of poly (oxyethylene)–poly (oxypropylene) block copolymers: implications for pharmaceutical dosage form design. J Appl Polym Sci 87:1016–26
  • Kewei Y, Delaney JT, Schubert US, Fahr A. (2012). Fast high-throughput screening of temoporfin-loaded liposomal formulations prepared by ethanol injection method. J Liposome Res 22:31–41
  • Lin HR, Sung KC. (2000). Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Release 69:379–88
  • Lindemann J, Richard L, Gerhard R, Tilman K. (2002). Nasal mucosal temperature during respiration. Clin Otolaryngol Allied Sci 27:135–9
  • Lopez-Pinto JM, Gonzalez-Rodriguez ML, Rabasco AM. (2005). Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 298:1–12
  • Maghraby M, Campbell M, Finnin BC. (2005). Mechanisms of action of novel skin penetration enhancers: phospholipid versus skin lipid liposomes. Int J Pharm 305:90–104
  • Nava D, Touitou E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21:1879–85
  • Pujara CP, Zezhi S, Michelle RD, Mitra AK. (1995). Effects of formulation variables on nasal epithelial cell integrity: biochemical evaluations. Int J Pharm 114:197–203
  • Pund S, Rasve G, Borade G. (2013). Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa. Eur J Pharm Sci 48:195–201
  • Robert B, Pagonabarraga J, Kulisevsky J. (2009). Individual triptan selection in migraine attack therapy. Recent Pat CNS Drug Discov 4:70–81
  • Roger Y, Nairn K, Dixon R, Emma S. (2002). Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers. J Clin Pharmacol 42:1237–43
  • Sarwa KK, Das PJ, Mazumder B. (2014). A nanovesicle topical formulation of Bhut Jolokia (hottest capsicum): a potential anti-arthritic medicine. Expert Opin Drug Deliv 11:661–76
  • Shelke S, Shahi S, Jalalpure S, et al. (2015). Formulation and evaluation of thermoreversible mucoadhesive in-situ gel for intranasal delivery of naratriptan hydrochloride. J Drug Deliv Sci Tech 29:238–44
  • Shin BK, Eun JB, Soon GC, et al. (2013). Preparation and irradiation of Pluronic F127-based thermoreversible and mucoadhesive hydrogel for local delivery of naproxen. Drug Dev Ind Pharm 39:1874–80
  • Siepmann J, Peppas NA. (2012). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Del Rev 64:163–74
  • Silberstein SD. (1995). Migraine symptoms: results of a survey of self-reported migraineurs. Headache 7:387–96
  • Solomon GD, Cady RK, Klapper JA, et al. (1997). Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. Neurology 49:1219–25
  • Verma P, Pathak K. (2012). Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine 8:489–96

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.